Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

Parental imprinting of the mouse insulin-like growth factor II gene

DeChiara, T. M., Robertson, E. J., & Efstratiadis, A. (1991) · Cell · doi:10.1016/0092-8674(91)90513-x · Cited by 1,804

Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome

Weinstein, L. S., Shenker, A., Gejman, P. V., Merino, M. J., Friedman, E., & Spiegel, A. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252403 · Cited by 1,697

Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex

Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153

The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity

Carney, J. A., Gordon, H., Carpenter, P. C., Shenoy, B. V., & Go, V. L. W. (1985) · Medicine · doi:10.1097/00005792-198507000-00007 · Cited by 1,110

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.Preprint

Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952

Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome

Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M. L., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 899

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.Preprint

Lee, M., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889

Relaxation of imprinted genes in human cancer

Rainier, S. R., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E., & Feinberg, A. P. (1993) · Nature · doi:10.1038/362747a0 · Cited by 795

Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour

Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J., & Reeve, A. E. (1993) · Nature · doi:10.1038/362749a0 · Cited by 706

Tumour-suppressor activity of H19 RNA

Hao, Y., Crenshaw, T., Moulton, T. A., Newcomb, E. W., & Tycko, B. (1993) · Nature · doi:10.1038/365764a0 · Cited by 629

Adrenocortical carcinoma

Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892

Adrenocortical Carcinoma: Clinical Update

Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775

Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations

Hagman, K. D. F., Noltner, K., Buzin, C. H., Gu, D., Wen, C. Y., Nguyen, V. Q., Han, J., Lowstuter, K. J., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 607

A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment

Hampel, H., Bennett, R. L., Buchanan, A. H., Pearlman, R., & Wiesner, G. L. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.147 · Cited by 606

Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients

Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435

Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling

Giordano, T. J., Kuick, R., Else, T., Gauger, P. G., Vinco, M., Bauersfeld, J., Sanders, D., Thomas, D. G., Doherty, G., & Hammer, G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1067 · Cited by 401

Clinical management of adrenocortical carcinoma

Fassnacht, M., & Allolio, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.008 · Cited by 349

Menin: a scaffold protein that controls gene expression and cell signaling

Matkar, S. S., Thiel, A. T., & Hua, X. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.05.005 · Cited by 295

Adrenocortical cancer: pathophysiology and clinical management

Libé, R., Fratticci, A., & Bertherat, J. Y. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01130 · Cited by 271

Adrenal Imaging

Blake, M. A., Cronin, C. G., & Boland, G. W. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4547 · Cited by 254

The Weiss system for evaluating adrenocortical neoplasms: 25 years later

Lau, S. K., & Weiss, L. M. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.03.010 · Cited by 223

Wnt/β-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic β-catenin gene mutations in the progression of adrenocortical tumors

Gaujoux, S., Tissier, F., Groussin, L., Libé, R., Ragazzon, B., Launay, P., Audebourg, A., Dousset, B., Bertagna, X., & Bertherat, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0631 · Cited by 142

Childhood adrenocortical tumours

Ribeiro, R. C., & de Figueiredo, B. C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.031 · Cited by 140

Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias

Stratakis, C. A., & Boikos, S. A. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0648 · Cited by 129

Wnt/β-catenin signalling in adrenal physiology and tumour development

Berthon, A., Martinez, A., Bertherat, J., & Val, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.009 · Cited by 125

Phosphodiesterase 11A (PDE11A) and Genetic Predisposition to Adrenocortical Tumors

Libé, R., Fratticci, A., Coste, J., Tissier, F., Horvath, A., Ragazzon, B., René-Corail, F., Groussin, L., BERTAGNA, X. Y., Raffin‐Sanson, M. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0106 · Cited by 128

Li‐Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition

Valdez, J. M., Nichols, K. E., & Kesserwan, C. A. (2016) · British Journal of Haematology · doi:10.1111/bjh.14461 · Cited by 124

Somatic TP53 Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17p13 Loss of Heterozygosity

Libè, R., Groussin, L., Tissier, F., Elie, C., René-Corail, F., Fratticci, A., Jullian, E., Beck-Peccoz, P., Bertagna, X., Gicquel, C., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2085 · Cited by 115

Large Deletions of the PRKAR1A Gene in Carney Complex

Horvath, A., Bossis, I., Giatzakis, C., Levine, E., Weinberg, F. D., Meoli, E., Robinson-White, A. J., Siegel, J., Soni, P., Groussin, L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1155 · Cited by 106

Menin Epigenetically Represses Hedgehog Signaling in MEN1 Tumor Syndrome

Gurung, B., Feng, Z., Iwamoto, D. V., Thiel, A. T., Jin, G., Fan, C.-M., Ng, J. M. Y., Curran, T., & Hua, X. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3158 · Cited by 101

Current management of adrenal tumors

Kuruba, R., & Gallagher, S. F. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f301fd · Cited by 85

Genetics of tumors of the adrenal cortex

Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80

Role of the Insulin-like Growth Factor System in Adrenocortical Growth Control and Carcinogenesis

Fottner, C., Hoeflich, A., Wolf, E., & Weber, M. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-814563 · Cited by 78

Transcriptional profiling enables molecular classification of adrenocortical tumours

Laurell, C., Velázquez‐Fernández, D., Lindsten, K., Juhlin, C. C., Enberg, U., Geli, J., Höög, A., Kjellman, M., Lundeberg, J., Hamberger, B., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0068 · Cited by 77

Adrenocortical carcinoma: The management of metastatic disease

Fay, A. P., Elfiky, A. A., Teló, G. H., McKay, R. R., Kaymakcalan, M. D., Nguyen, P. L., Vaidya, A., Ruan, D. T., Joaquim Bellmunt, B., & Choueiri, T. K. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.05.009 · Cited by 69

Update on tumours of the adrenal cortex, phaeochromocytoma and extra‐adrenal paraganglioma

McNicol, A. M. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03613.x · Cited by 68

REVIEW PAPER: Origin and Molecular Pathology of Adrenocortical Neoplasms

Bielińska, M., Parviainen, H., Kiiveri, S., Heikinheimo, M., & Wilson, D. B. (2009) · Veterinary Pathology · doi:10.1354/vp.08-vp-0179-w-rev · Cited by 68

Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease

de Crémoux, P., Rosenberg, D., Goussard, J., Brémont-Weil, C., Tissier, F., Tran‐Perennou, C., Groussin, L., BERTAGNA, X. Y., Bertherat, J. Y., & Raffin‐Sanson, M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0081 · Cited by 63

The molecular genetics of adrenocortical carcinoma

Barlaskar, F. M., & Hammer, G. D. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9057-x · Cited by 56

Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway

Delhanty, P. J. D., van Koetsveld, P. M., Gauna, C., van de Zande, B., Vitale, G., Hofland, L. J., & van der Lely, A. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00377.2006 · Cited by 55

Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome

Adam, P., Hahner, S., Hartmann, M., Heinrich, B., Quinkler, M. O., Willenberg, H. S., Saeger, W., Sbiera, S., Schmull, S., Voelker, H.-U., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.153 · Cited by 55

Pathogenesis of adrenocortical cancer

Bertherat, J. Y., & BERTAGNA, X. Y. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.006 · Cited by 55

Adrenocortical tumors and hyperplasias in childhood--etiology, genetics, clinical presentation and therapy.

Sutter, J. A., & Grimberg, A. (2006) · PubMed · Cited by 51

GENETICS IN ENDOCRINOLOGY: Glucocorticoid resistance syndrome

Vitellius, G., & Lombès, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0811 · Cited by 49

Preoperative 18F‐FDG Uptake is Strongly Correlated with Malignancy, Weiss Score, and Molecular Markers of Aggressiveness in Adrenal Cortical Tumors

Gust, L., Taïeb, D., Beliard, A., Barlier, A., Morange, I., Micco, C. D., Henry, J., & Sebag, F. A. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1374-2 · Cited by 48

The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells

Martino, M. C. D., van Koetsveld, P. M., Feelders, R. A., Sprij-Mooij, D. M., Waaijers, M., Lamberts, S. W. J., de Herder, W. W., Colao, A., Pivonello, R., & Hofland, L. J. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0270 · Cited by 48

Menin Directly Represses Gli1 Expression Independent of Canonical Hedgehog Signaling

Gurung, B., Feng, Z., & Hua, X. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0170 · Cited by 46

Clinical impact of TP53 alterations in adrenocortical carcinomas

Waldmann, J., Patsalis, N., Fendrich, V., Langer, P., Saeger, W., Chaloupka, B., Ramaswamy, A., Faßnacht, M., Bartsch, D. K., & Slater, E. P. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0868-6 · Cited by 45

The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses

Assié, G., Guillaud-Bataille, M., Ragazzon, B., BERTAGNA, X. Y., Bertherat, J. Y., & Clauser, É. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.12.009 · Cited by 48

P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model

Batisse‐Lignier, M., Sahut‐Barnola, I., Tissier, F., Dumontet, T., Mathieu, M., Drelon, C., Pointud, J.-C., Damon‐Soubeyrand, C., Marceau, G., Kemeny, J.-L., et al. (2017) · Oncogene · doi:10.1038/onc.2017.54 · Cited by 42

The Genetics of Adrenocortical Tumors

Espiard, S., & Bertherat, J. Y. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.004 · Cited by 47

Gene expression profiling in adrenocortical neoplasia

Assié, G., Giordano, T. J., & Bertherat, J. Y. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.044 · Cited by 41

Li–Fraumeni syndrome heterogeneity

Gargallo, P., Yáñez, Y., Segura, V., Juan, A., Torres, B., Balaguer, J., Oltra, S., Castel, V., & Cañete, A. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02236-2 · Cited by 41

Mechanisms of Disease: adrenocortical tumors—molecular advances and clinical perspectives

Bertherat, J. Y., Groussin, L., & BERTAGNA, X. Y. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0321 · Cited by 40

The indeterminate adrenal lesion

Sahdev, A., Willatt, J. M., Francis, I. R., & Reznek, R. H. (2010) · Cancer Imaging · doi:10.1102/1470-7330.2010.0012 · Cited by 39

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer

Martino, M. C. D., van Koetsveld, P. M., Feelders, R. A., de Herder, W. W., Dogan, F., Janssen, J. A. M. J. L., Bruinink, D. H. O., Pivonello, C., Waaijers, A. M., Colao, A., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01869-1 · Cited by 39

Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome

Vaduva, P., Bonnet-Serrano, F., & Bertherat, J. Y. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa075 · Cited by 35

Sex steroids in androgen-secreting adrenocortical tumors: clinical and hormonal features in comparison with non-tumoral causes of androgen excess

d’Alva, C. B., Abiven, G., Viallon, V., Groussin, L., Dugué, M. A., BERTAGNA, X. Y., & Bertherat, J. Y. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0324 · Cited by 36

Adrenocortical Cancer Treatment

Patalano, A., Brancato, V., & Mantero, F. (2009) · Hormone Research in Paediatrics · doi:10.1159/000178049 · Cited by 34

Classification of adrenal cortical tumors: What limits for the pathological approach?

Tissier, F. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.011 · Cited by 34

Adrenocortical Cancer in Carney Complex: A Paradigm of Endocrine Tumor Progression or an Association of Genetic Predisposing Factors?

Bertherat, J. Y. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3327 · Cited by 33

How to Differentiate Benign from Malignant Adrenocortical Tumors?

Viëtor, C. L., Creemers, S. G., van Kemenade, F. J., van Ginhoven, T. M., Hofland, L. J., & Feelders, R. A. (2021) · Cancers · doi:10.3390/cancers13174383 · Cited by 33

Differential Expression of Parathyroid Hormone–Related Protein in Adrenocortical Tumors: Autocrine/Paracrine Effects on the Growth and Signaling Pathways in H295R Cells

Rizk‐Rabin, M., Assié, G., René-Corail, F., Perlemoine, K., Hamzaoui, H., Tissier, F., Lieberherr, M., BERTAGNA, X. Y., Bertherat, J. Y., & Bouizar, Z. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2924 · Cited by 30

Expression of TIP30 Tumor Suppressor Gene Is Down-Regulated in Human Colorectal Carcinoma

Chen, X., Cao, X., Dong, W., Luo, S., Suo, Z., & Jin, Y. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0992-0 · Cited by 28

The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas

Chambre, C., McMurray, E. M., Baudry, C., Lataud, M., Guignat, L., Gaujoux, S., Lahlou, N., Guibourdenche, J., Tissier, F., Sibony, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0036 · Cited by 29

Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors

Martino, M. C. D., Feelders, R. A., de Herder, W. W., van Koetsveld, P. M., Dogan, F., Janssen, J. A. M. J. L., Waaijers, A. M., Pivonello, C., Lamberts, S. W. J., Colao, A., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0112 · Cited by 27

Molecular pathology of adrenal cortical tumors: Separating adenomas from carcinomas

Giordano, T. J. (2006) · Endocrine Pathology · doi:10.1007/s12022-006-0007-z · Cited by 27

Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.

Vincent-Dejean, C., Cazabat, L., Groussin, L., Perlemoine, K., Fumey, G., Tissier, F., BERTAGNA, X. Y., & Bertherat, J. Y. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0819 · Cited by 26

Menin Is Required for Optimal Processing of the MicroRNA let-7a

Gurung, B., Muhammad, A. B., & Hua, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.520692 · Cited by 26

Characteristics of Li‐Fraumeni syndrome in Japan: A review study by the special committee of JSHT

Funato, M., Tsunematsu, Y., Yamazaki, F., Tamura, C., Kumamoto, T., Takagi, M., Kato, S., Sugimura, H., & Tamura, K. (2021) · Cancer Science · doi:10.1111/cas.14919 · Cited by 24

The indeterminate adrenal mass in patients with cancer

Sahdev, A. (2007) · Cancer Imaging · doi:10.1102/1470-7330.2007.9017 · Cited by 24

The role of epithelial growth factors and insulin growth factors in the adrenal neoplasms

Angelousi, A. G., Kyriakopoulos, G., Ansari, N. N., Karageorgou, M., & Kassi, E. N. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.05.52 · Cited by 25

A Rare Cause of Hypertestosteronemia in a 68‐Year‐Old Patient: A Leydig Cell Tumor Due to a Somatic GNAS (Guanine Nucleotide‐Binding Protein, Alpha‐Stimulating Activity Polypeptide 1)–Activating Mutation

Libé, R., Fratticci, A., Lahlou, N., Jornayvaz, F. R., Tissier, F., Louiset, E., Guibourdenche, J., Vieillefond, A., Zerbib, M., & Bertherat, J. Y. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.013441 · Cited by 22

Childhood Adrenocortical Tumours: a Review

Pereira, R. M., DeLacerda, L., Lacerda, H. M., Michalkiewicz, E., Sandrini, F., & Sandrini, R. (2006) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-4-2-81 · Cited by 22

Precursor Lesions of the Adrenal Gland

van Nederveen, F. H., & de Krijger, R. R. (2007) · Pathobiology · doi:10.1159/000105811 · Cited by 22

Primary adrenal angiosarcoma and functioning adrenocortical adenoma: an exceptional combined tumor

Lussey‐Lepoutre, C., Rousseau, A., Ghuzlan, A. A., Amar, L., Hignette, C., Cioffi, A., Zinzindohoué, F., Leboulleux, S., & Plouin, P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0791 · Cited by 22

Syndromes de Cushing : physiopathologie, étiologie et principes thérapeutiques

Chabre, O. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.02.001 · Cited by 21

Clinical and molecular prognostic factors in adrenocortical carcinoma

Libé, R. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02900-0 · Cited by 21

Genetic Alterations in Benign Adrenal Tumors

Pitsava, G., & Stratakis, C. A. (2022) · Biomedicines · doi:10.3390/biomedicines10051041 · Cited by 20

Novel Insights into the Genetics and Pathophysiology of Adrenocortical Tumors

Drougat, L., Omeiri, H., Lefèvre, L., & Ragazzon, B. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00096 · Cited by 19

mRNA and microRNA expression patterns in adrenocortical cancer.

Zsippai, A., Szabó, D. R., Szabó, P. M., Tömböl, Z., Bendes, M. R., Nagy, Z., Rácz, K., & Igaz, P. (2011) · PubMed Central · Cited by 19

Virilizing Adrenocortical Carcinoma Advancing to Central Precocious Puberty after Surgery

Kim, M. S., Yang, E. J., Cho, D. H., Hwang, P. H., & Lee, D. (2015) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2015.36.3.150 · Cited by 18

Molecular markers of adrenocortical tumors

Jain, M., Rechache, N. S., & Kebebew, E. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23119 · Cited by 17

The clinical spectrum of adrenocortical hyperplasia

SCHTEINGART, D. E. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283537ee9 · Cited by 15

Detection of polyomaviruses and herpesviruses in human adrenal tumors

Barzon, L., Trevisan, M., Masi, G., Pacenti, M., Sinigaglia, A., Macchi, V., Porzionato, A., Caro, R. D., Favia, G., Iacobone, M., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210699 · Cited by 15

The Role of gsp Mutations on the Development of Adrenocortical Tumors and Adrenal Hyperplasia

Fragoso, M. C. B. V., Wanichi, I. Q., Cavalcante, I. P., & Mariani, B. M. P. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00104 · Cited by 15

TIP30: A Novel Tumor-Suppressor Gene

Yu, X., Li, Z., & Wu, W. K. K. (2015) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504015x14424348426116 · Cited by 14

Disorders of the adrenal cortex: Genetic and molecular aspects

Pitsava, G., Maria, A. G., & Faucz, F. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931389 · Cited by 13

Functional genomics approaches for the study of sporadic adrenal tumor pathogenesis: Clinical implications

Igaz, P., Wiener, Z., Szabó, P. M., Falus, A., Gaillard, R. C., Horányi, J., Rácz, K., & Tulassay, Z. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.06.011 · Cited by 13

Androgen-Secreting Adrenal and Ovarian Neoplasms

PUGEAT, M. M., Raverot, G., Plotton, I., de la Perrière, A. B., Mirakian, P., Déchaud, H., Berger, N., & Peix, J. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_6 · Cited by 12

Adrenal mass in patients who underwent abdominal computed tomography examination

El-Menyar, A. A., Al-Sulaiti, M., Elgohary, H., Almalki, A., Asim, M., Tabeb, A., & Al-Thani, H. A. S. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.157482 · Cited by 12

Current Update on Cytogenetics, Taxonomy, Diagnosis, and Management of Adrenocortical Carcinoma: What Radiologists Should Know

Ganeshan, D., Bhosale, P., & Kundra, V. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.8282 · Cited by 12

Genetic information in the diagnosis and treatment of hypertension

Tomaszewski, M., Zimmerli, L., Charchar, F. J., & Dominiczak, A. F. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0070-3 · Cited by 12

Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) for the diagnosis of Cushing's syndrome: Genetics of Cushing's syndrome

Martinerie, L., Bouligand, J., North, M.-O., Bertherat, J. Y., Assié, G., & Espiard, S. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.01.005 · Cited by 11

A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma

Bulzico, D., Torres, D. C., Ferreira, G. M., Pires, B. R. B., de Faria, P. A. S., Hassan, R., Abdelhay, E. S. F. W., Vaisman, M., & Neto, L. V. (2017) · Endocrine Pathology · doi:10.1007/s12022-017-9482-7 · Cited by 11

Szlaki molekularne w raku kory nadnercza — od wiedzy o sygnalizacji komórkowej do metod diagnostyki i leczenia

Szyszka, P., Grossman, A. B., Díaz‐Cano, S. J., & Dorota Dworakowska, B. (2015) · Endokrynologia Polska · doi:10.5603/ep.a2016.0054 · Cited by 11

Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas

Ye, J., Qi, Y., Wang, W., Sun, F., Qin, W. D., Su, T., Zhou, W., Jiang, Y., Yuan, W.-Q., Cai, J.-F., et al. (2012) · Endocrine · doi:10.1007/s12020-012-9593-3 · Cited by 10

Pubertal outcome in a female with virilizing adrenocortical carcinoma

Breidbart, E., Cameo, T., Garvin, J. H., Hibshoosh, H. H., & Oberfield, S. E. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0123 · Cited by 8

Pathogenesis of adrenocortical cancer

Szabó, D. R., Zsippai, A., Bendes, M. R., Tömböl, Z., Szabó, P. M., Rácz, K., & Igaz, P. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28931 · Cited by 8

Genetics of adrenocortical disease

Bar-Lev, A., & Annes, J. P. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328352f013 · Cited by 8

Cushing's Syndrome in an Infant Secondary to Malignant Adrenocortical Tumors with Somatic Mutation of Beta-Catenin

Pusantisampan, T., Sangkhathat, S., Kayasut, K., Kanngurn, S., Jaruratanasirikul, S., Chotsampancharoen, T., & Kritsaneepaiboon, S. (2009) · Pediatric and Developmental Pathology · doi:10.2350/09-07-0683-cr.1 · Cited by 9

Adrenocortical Growth and Cancer

Lefèvre, L., Bertherat, J. Y., & Ragazzon, B. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140010 · Cited by 12

Hsp90 inhibition in adrenocortical carcinoma: Limited drug synergism with mitotane

Sbiera, S., Kendl, S., Weigand, I., Sbiera, I., Faßnacht, M., & Kroiß, M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.009 · Cited by 7

Beyond BRCA1 and BRCA2

King-Spohn, K., & Pilarski, R. (2014) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2014.10.004 · Cited by 7

Pathogenesis of benign adrenocortical tumors

Vezzosi, D., Bertherat, J. Y., & Groussin, L. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.005 · Cited by 7

Adrenocortical neoplasms in young children: age as a prognostic factor.

Ahmed, A. A. (2009) · PubMed · Cited by 7

Adrenocortical Carcinoma

Elfiky, A. A. (2015) · Surgical pathology clinics · doi:10.1016/j.path.2015.07.002 · Cited by 7

Hereditary Risk for Cancer

Hunt, K. S., Ray, J. A., & Jeter, J. (2013) · Springer eBooks · doi:10.1007/978-3-642-38983-2_5 · Cited by 6

p53 Testing for Li‐Fraumeni and Li‐Fraumeni‐Like Syndromes

Hagman, K. D. F., Fong, C., Buzin, C. H., Sommer, S. S., & Saldivar, J. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1010s57 · Cited by 6

Genomic medicine for cancer diagnosis

Gordon, B. L., Finnerty, B. M., Aronova, A., & Fahey, T. J. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23778 · Cited by 5

REVIEW Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

Libé, R., & Bertherat, J. Y. (2013)

Genetics of Adrenocortical Tumors (ACT) and Hypersecretory Syndromes

Libé, R., Groussin, L., Bertherat, J. Y., & BERTAGNA, X. Y. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00016-x

Genetic aspects of adrenocortical tumours and hyperplasias

Mazzuco, T. L., Durand, J., Chapman, A., Crespigio, J., & Bourdeau, I. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04403.x · Cited by 47

Mechanisms of Disease: adrenocortical tumors—molecular advances and clinical perspectives

Bertherat, J. Y., Groussin, L., & BERTAGNA, X. Y. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0321 · Cited by 40

Genetics of adrenal tumors

Lerário, A. M., Mohan, D. R., Giordano, T. J., & Hammer, G. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00013-7